Mesenteric Venous Thrombosis Clinical Trials

Find Mesenteric Venous Thrombosis Clinical Trials Near You

Comparison Of Different Mechanical Thrombectomy Devices in Endovascular Treatment of Acute Iliofemoral Venous Thrombosis (The COMET Study)

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

A head-to-head comparison of two different types of percutaneous mechanical thrombectomy (PMT) - ClotTriever System versus aspiration thrombectomy (including rheolytic thrombectomy) - in patients with acute iliofemoral deep vein thrombosis (DVT) was conducted to determine whether ClotTriever System can improve thrombus clearance rate, reduce the incidence of post-thrombotic syndrome (PTS), and enhance the long-term efficacy of endovascular treatment for acute iliofemoral DVT.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• Aged between 18 and 85 years;

• Diagnosed with acute iliofemoral venous thrombosis, with thrombosis involving at least the iliac vein and common femoral vein;

• Time from symptom onset to endovascular treatment ≤ 14 days;

• Patients undergo endovascular treatment with percutaneous mechanical thrombectomy;

• Patients sign the informed consent form.

Locations
Other Locations
China
Renji hospital
RECRUITING
Shanghai
Contact Information
Primary
Qihong Ni
niqihong1989@163.com
+8615801900772
Time Frame
Start Date: 2024-01-01
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 180
Treatments
ClotTriever System group
Patients receive percutaneous mechanical thrombectomy by ClotTriever System
Aspiration thrombectomy group
Patients receive percutaneous mechanical thrombectomy by aspiration or rheolytic thrombectomy
Sponsors
Collaborators: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University, West China Hospital, First People's Hospital of Hangzhou, Wenzhou Central Hospital, Chengdu University of Traditional Chinese Medicine, Changhai Hospital
Leads: RenJi Hospital

This content was sourced from clinicaltrials.gov